Top Story

Tumor profiling model finds potential therapeutic agents for HCC

March 30, 2015

In a retrospective study, researchers used Caris Molecular Intelligence to identify molecular patterns and therapeutic options for hepatocellular carcinoma and presented the data at the 68th Annual Cancer Symposium of the Society of Surgical Oncology in Houston, according to a news release.

Caris Molecular Intelligence (Caris Life Sciences) is a tumor profiling service that includes gene sequencing, protein expression analysis and gene copy number analysis to show the molecular differences in HCC. The approach was used among 313 tumor samples of patients with HCC to describe molecular patterns and associations and also to identify potential therapeutic targets, according to the release.

In the Journals

Aprepitant effective for CINV prevention in children

March 30, 2015
The addition of aprepitant to ondansetron effectively reduced or prevented chemotherapy-induced nausea and vomiting in pediatric patients who underwent moderately or…
Institution Notes

Gynecologic oncologist becomes network's physician director

March 29, 2015
Thomas J. Rutherford, MD, PhD, has been named network physician director of cancer services at Western Connecticut Health Network.Rutherford, a gynecologic oncologist…
Keith Flaherty Institution Notes

Cancer center names director of clinical research

March 28, 2015
Keith Flaherty, MD, has been appointed director of clinical research at Massachusetts General Hospital Cancer Center.
thumbnail for video 4139087567001 Meeting News CoverageVideo

VIDEO: 'Full spectrum' of melanoma prevention, treatment options available

March 27, 2015
SAN FRANCISCO — In this video, Sancy A Leachman, MD, PhD, discusses the latest developments in the prevention and treatment of melanoma the American Academy of…
More News Headlines »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
thumbnail for video 4126759064001

Solid organ transplant recipients at higher risk for skin cancer

March 22, 2015
SAN FRANCISCO – In this video, Sarah Tuttleton Arron, MD, PhD, FAAD, discusses her research on mortality from…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan
morganatic-roan